Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


Articles published in Cancer Lett

Retrieve available abstracts of 18 articles:
HTML format
Text format



Single Articles


    December 2018
  1. TANG YL, Sun X, Huang LB, Liu XJ, et al
    Melatonin inhibits MLL-rearranged leukemia via RBFOX3/hTERT and NF-kappaB/COX-2 signaling pathways.
    Cancer Lett. 2018 Dec 10. pii: S0304-3835(18)30703.
    PubMed     Text format     Abstract available


    October 2018
  2. ZHANG JM, Wang CC, Zhang GC, Jiang Q, et al
    ADAM28 promotes tumor growth and dissemination of acute myeloid leukemia through IGFBP-3 degradation and IGF-I-induced cell proliferation.
    Cancer Lett. 2018;442:193-201.
    PubMed     Text format     Abstract available


    September 2018
  3. WANG Y, Chen H, Chen J, Han M, et al
    The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China.
    Cancer Lett. 2018;438:63-75.
    PubMed     Text format     Abstract available


    June 2018
  4. LEE YC, Wang LJ, Huang CH, Shi YJ, et al
    ABT-263-induced MCL1 upregulation depends on autophagy-mediated 4EBP1 downregulation in human leukemia cells.
    Cancer Lett. 2018 Jun 15. pii: S0304-3835(18)30417.
    PubMed     Text format     Abstract available


    May 2018
  5. ZHANG X, Zheng X, Yang H, Yan J, et al
    Piribedil disrupts the MLL1-WDR5 interaction and sensitizes MLL-rearranged acute myeloid leukemia (AML) to doxorubicin-induced apoptosis.
    Cancer Lett. 2018 May 29. pii: S0304-3835(18)30367.
    PubMed     Text format     Abstract available


    March 2018
  6. HU X, Mei S, Meng W, Xue S, et al
    CXCR4-mediated signaling regulates autophagy and influences acute myeloid leukemia cell survival and drug resistance.
    Cancer Lett. 2018 Mar 21. pii: S0304-3835(18)30221.
    PubMed     Text format     Abstract available


  7. FARAONI I, Aloisio F, De Gabrieli A, Consalvo MI, et al
    The poly(adp-ribose) polymerase inhibitor olaparib induces up-regulation of death receptors in primary acute myeloid leukemia blasts by nf-kappab activation.
    Cancer Lett. 2018 Mar 8. pii: S0304-3835(18)30197.
    PubMed     Text format     Abstract available


    February 2018
  8. VELA M, Corral D, Carrasco P, Fernandez L, et al
    Haploidentical IL-15/41BBL activated and expanded natural killer cell infusion therapy after salvage chemotherapy in children with relapsed and refractory leukemia.
    Cancer Lett. 2018 Feb 22. pii: S0304-3835(18)30172.
    PubMed     Text format     Abstract available


  9. HE Y, Sun L, Xu Y, Fu L, et al
    Combined inhibition of PI3Kdelta and FLT3 signaling exerts synergistic antitumor activity and overcomes acquired drug resistance in FLT3-activated acute myeloid leukemia.
    Cancer Lett. 2018;420:49-59.
    PubMed     Text format     Abstract available


  10. TORELLO CO, Shiraishi RN, Della Via FI, Castro TCL, et al
    Reactive oxygen species production triggers green tea-induced anti-leukaemic effects on acute promyelocytic leukaemia model.
    Cancer Lett. 2018;414:116-126.
    PubMed     Text format     Abstract available


    January 2018
  11. DE COLA A, Franceschini M, Di Matteo A, Colotti G, et al
    N6L pseudopeptide interferes with nucleophosmin protein-protein interactions and sensitizes leukemic cells to chemotherapy.
    Cancer Lett. 2018;412:272-282.
    PubMed     Text format     Abstract available


    October 2017
  12. WEN S, Wang J, Liu P, Li Y, et al
    Novel combination of histone methylation modulators with therapeutic synergy against acute myeloid leukemia in vitro and in vivo.
    Cancer Lett. 2017 Oct 22. pii: S0304-3835(17)30650.
    PubMed     Text format     Abstract available


    September 2017
  13. COLLADO R, Puiggros A, Lopez-Guerrero JA, Calasanz MJ, et al
    Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes.
    Cancer Lett. 2017 Sep 6. pii: S0304-3835(17)30536.
    PubMed     Text format     Abstract available


  14. SADRAS T, Heatley SL, Kok CH, Dang P, et al
    Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions.
    Cancer Lett. 2017 Sep 1. pii: S0304-3835(17)30521.
    PubMed     Text format     Abstract available


    August 2017
  15. PRIGOZHINA TB, Szafer F, Aronin A, Tzdaka K, et al
    Fn14.TRAIL fusion protein is oligomerized by TWEAK into a superefficient TRAIL analog.
    Cancer Lett. 2017;400:99-109.
    PubMed     Text format     Abstract available


    July 2017
  16. MOHARRAM SA, Shah K, Khanum F, Marhall A, et al
    Efficacy of CDK inhibitor dinaciclib in vitro and in vivo in T-cell acute lymphoblastic leukemia.
    Cancer Lett. 2017 Jul 26. pii: S0304-3835(17)30455.
    PubMed     Text format     Abstract available


    April 2017
  17. ESPINOZA JL, Elbadry MI, Taniwaki M, Harada K, et al
    The simultaneous inhibition of the mTOR and MAPK pathways with Gnetin-C induces apoptosis in acute myeloid leukemia.
    Cancer Lett. 2017 Apr 26. pii: S0304-3835(17)30288.
    PubMed     Text format     Abstract available


    February 2017
  18. PIAO J, Takai S, Kamiya T, Inukai T, et al
    Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF-positive leukemic cells.
    Cancer Lett. 2017;386:131-140.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: